The predictive value of machine learning and nomograms for lymph node metastasis of prostate cancer: a systematic review and meta-analysis
- PMID: 37488275
- DOI: 10.1038/s41391-023-00704-z
The predictive value of machine learning and nomograms for lymph node metastasis of prostate cancer: a systematic review and meta-analysis
Abstract
Background: In clinical practice, there are currently a variety of nomograms for predicting lymph node metastasis (LNM) of prostate cancer. At the same time, some scholars have introduced machine learning (ML) into the prediction of LNM of prostate cancer. However, the predictive value of nomograms and ML remains controversial. Based on this situation, this systematic review and meta-analysis was performed to explore the predictive value of various nomograms currently recommended and newly-developed ML models for LNM in prostate cancer patients.
Evidence acquisition: Cochrane, PubMed, Embase, and Web of Science were searched up to November 1, 2022. The risk of bias in the included studies was evaluated using the Prediction model Risk of Bias Assessment Tool (PROBAST). The concordance index (C-index), sensitivity, and specificity were adopted to evaluate the predictive accuracy of the models.
Results: Thirty-one studies (18,803 patients) were included. Seven kinds of nomograms currently recommended, dominated by Briganti nomogram or MSKCC nomogram, were covered in the included studies. For newly-developed ML models, the C-index for LNM prediction in the training set and validation set was 0.846 [95%CI (0.818, 0.873)] and 0.862 [95%CI (0.819-0.905)] respectively. Most ML models in the training set were based on Logistic Regression (LR), which had a sensitivity of 0.78 [95%CI (0.70, 0.85)] and a specificity of 0.85 [95%CI (0.77, 0.90)] in the training set, and a sensitivity of 0.81 [95%CI (0.67, 0.89)] and a specificity of 0.82 [95%CI (0.75, 0.88)] in the validation set. For the recommended nomograms, the C-index in the validation set was 0.745 [95%CI (0.701, 0.790)] for the Briganti nomogram and 0.714 [95%CI (0.662, 0.765)] for the MSKCC nomogram.
Conclusion: The predictive accuracy of ML is superior to existing clinically recommended nomograms, and appropriate updates can be conducted to existing nomograms according to special situations.
© 2023. The Author(s), under exclusive licence to Springer Nature Limited.
Similar articles
-
Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.Urology. 2022 Oct;168:156-164. doi: 10.1016/j.urology.2022.04.043. Epub 2022 Jul 5. Urology. 2022. PMID: 35803346
-
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging.BJU Int. 2021 Aug;128(2):236-243. doi: 10.1111/bju.15376. Epub 2021 May 16. BJU Int. 2021. PMID: 33630398
-
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68 Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7. BJU Int. 2021. PMID: 32524748
-
The value of machine learning in preoperative identification of lymph node metastasis status in endometrial cancer: a systematic review and meta-analysis.Front Oncol. 2023 Dec 20;13:1289050. doi: 10.3389/fonc.2023.1289050. eCollection 2023. Front Oncol. 2023. PMID: 38173835 Free PMC article.
-
Diagnostic performance of prediction models for extraprostatic extension in prostate cancer: a systematic review and meta-analysis.Insights Imaging. 2023 Aug 22;14(1):140. doi: 10.1186/s13244-023-01486-7. Insights Imaging. 2023. PMID: 37606802 Free PMC article. Review.
Cited by
-
Index tumor location affected early biochemical recurrence after radical prostatectomy in patients with negative surgical margin: a retrospective study.BMC Urol. 2024 May 18;24(1):108. doi: 10.1186/s12894-024-01499-4. BMC Urol. 2024. PMID: 38762458 Free PMC article.
-
Clinical impact of MRI-based risk calculators for prostate cancer diagnosis: a systematic review and meta-analysis.Prostate Cancer Prostatic Dis. 2025 Aug 26. doi: 10.1038/s41391-025-01014-2. Online ahead of print. Prostate Cancer Prostatic Dis. 2025. PMID: 40858922 Review.
-
Analysis of biopsy pathology and risk factors of lymph node metastasis in prostate cancer.Int Urol Nephrol. 2024 Jul;56(7):2261-2267. doi: 10.1007/s11255-023-03931-4. Epub 2024 Feb 23. Int Urol Nephrol. 2024. PMID: 38393409
-
Quality of information and appropriateness of Open AI outputs for prostate cancer.Prostate Cancer Prostatic Dis. 2025 Mar;28(1):229-231. doi: 10.1038/s41391-024-00789-0. Epub 2024 Jan 16. Prostate Cancer Prostatic Dis. 2025. PMID: 38228809
-
Predictive modeling for metastasis in oncology: current methods and future directions.Ann Med Surg (Lond). 2025 May 21;87(6):3489-3508. doi: 10.1097/MS9.0000000000003279. eCollection 2025 Jun. Ann Med Surg (Lond). 2025. PMID: 40486555 Free PMC article. Review.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209–49. - DOI
-
- von Bodman C, Godoy G, Chade DC, Cronin A, Tafe LJ, Fine SW, et al. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. J Urol. 2010;184:143–8. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical